Evidence map›Paper›PMID 36656312›Full record

ArticleCannabis and cannabinoid research2024

Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm.

Mohammed A Mustafa, Justin L Poklis, Kimberly N Karin, Jayden A Elmer, Joseph H Porter, Victoria Parra, Dai Lu, Joel E Schlosburg, Aron H Lichtman

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mohammed A MustafaDepartment of Pharmacology and Toxicology, and Virginia Commonwealth University, Richmond, Virginia, USA.
Justin L PoklisDepartment of Pharmacology and Toxicology, and Virginia Commonwealth University, Richmond, Virginia, USA.
Kimberly N KarinDepartment of Pharmacology and Toxicology, and Virginia Commonwealth University, Richmond, Virginia, USA.
Jayden A ElmerDepartment of Pharmacology and Toxicology, and Virginia Commonwealth University, Richmond, Virginia, USA.
Joseph H PorterDepartment of Psychology, Virginia Commonwealth University, Richmond, Virginia, USA.
Victoria ParraDepartment of Pharmaceutical Sciences, Texas A&M, College Station, Texas, USA.
Dai LuDepartment of Pharmaceutical Sciences, Texas A&M, College Station, Texas, USA.
Joel E SchlosburgDepartment of Pharmacology and Toxicology, and Virginia Commonwealth University, Richmond, Virginia, USA.
Aron H LichtmanDepartment of Pharmacology and Toxicology, and Virginia Commonwealth University, Richmond, Virginia, USA.
Virginia Commonwealth University · USTexas College · US

Funding

Oleoyl Glycine-induced reduction of Nicotine Seeking: Bioanalytical & Behavioral ApproachesF31DA056228 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KARIN, KIMBERLY NICOLE · 2022 to 2023
$53k
NIDA NIH HHS F31 DA056228
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolAnimalsCannabinoid Receptor AgonistsCyclohexanolsEndocannabinoidsHumansMiceMice, Inbred C57BL3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanolCannabidiolCannabinoid Receptor AgonistsCyclohexanolsEndocannabinoidsallosteric modulatoranandamidecannabidiolcannabinoiddrug discriminationfatty acid amide hydrolase

Identifiers

PMID36656312
PMCPMC10998012
OpenAlexW4317437000

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.